Manhattan Scientifics Announces Fully Reporting Status, Applies For Listing On OTCBB
May 6, 2009
NEW YORK--Manhattan Scientifics, Inc. (Pink Sheets: MHTX) announced today that the company has filed its Form 10-K for the fiscal year ended December 31, 2008, is now current in its periodic reporting with the SEC and is seeking a quotation on the Over-the-Counter Bulletin Board.
The company has provided information to a broker dealer who, on behalf of the company, has filed a Form 211 application for the OTCBB quotation.
The company will provide an update to shareholders once it receives information from the broker dealer on the status of the application.
CEO Manny Tsoupanarias said, "Throughout most of our 11 year history, MHTX has traded on the OTCBB. I am delighted to see us returning to this system with our current reporting status.”
About Manhattan Scientifics
Manhattan Scientifics Inc. (www.mhtx.com) is located in New Mexico, New York and Montreal. It is focused on technology transfer and commercialization of disruptive technologies in the nano medicine space. The company is presently developing commercial medical prosthetics applications for its ultra-fine grain metals and plans to commercialize the cancer research work and nano medical applications developed by Senior Scientific LLC, a unit of the Company.
This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.
Manhattan Scientifics, Inc.
Marvin Maslow, Director of PR & IR, 917-923-3300
Herbert Strauss, +43-316-296-316
U.S. & Canadian Investor Relations
Hawk Associates: Frank Hawkins, 305-451-1888